Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Phase 2 data showed mean body weight reductions of approximately 24% over 48 weeks at the highest dose
Topically applied L-carnitine effectively reduces sebum secretion in human skin
A new analysis of data from the SELECT trial shows that semaglutide, a GLP-1 receptor agonist, provides a clear cardiovascular protective effect in people with overweight or obesity and already established cardiovascular disease, even when they do not have diabetes
Oxidative stress: role and response of short guanine tracts at genomic locations
Note: these values are estimates
US$ 27.80
US$ 24.91
US$ 22.61
US$ 23.58
